{"id":"https://openalex.org/W2059616065","doi":"https://doi.org/10.1111/dom.12329","title":"Modulation of insulin dose titration using a hypoglycaemia\u2010sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin\u2010na\u00efve people with type 2 diabetes","display_name":"Modulation of insulin dose titration using a hypoglycaemia\u2010sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin\u2010na\u00efve people with type 2 diabetes","publication_year":2014,"publication_date":"2014-06-24","ids":{"openalex":"https://openalex.org/W2059616065","doi":"https://doi.org/10.1111/dom.12329","mag":"2059616065","pmid":"https://pubmed.ncbi.nlm.nih.gov/24957785","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4282751"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12329","doi":"https://doi.org/10.1111/dom.12329","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12329","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12329","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12329","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108247584","display_name":"P. D. Home","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"P. D. Home","raw_affiliation_strings":["Institute for Cellular Medicine\u00a0\u2013\u00a0Diabetes Newcastle University  Newcastle upon Tyne UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cellular Medicine\u00a0\u2013\u00a0Diabetes Newcastle University  Newcastle upon Tyne UK","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057323309","display_name":"Geremia B. Bolli","orcid":"https://orcid.org/0000-0003-4966-4003","observed_orcids":["https://orcid.org/0000-0003-4966-4003"]},"institutions":[{"id":"https://openalex.org/I27483092","display_name":"University of Perugia","ror":"https://ror.org/00x27da85","country_code":"IT","type":"education","lineage":["https://openalex.org/I27483092"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. B. Bolli","raw_affiliation_strings":["Department of Medicine, University of Perugia, Perugia Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Perugia, Perugia Italy","institution_ids":["https://openalex.org/I27483092"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053469409","display_name":"Chantal Mathieu","orcid":"https://orcid.org/0000-0002-4055-5233","observed_orcids":["https://orcid.org/0000-0002-4055-5233","https://orcid.org/0000-0002-6099-2406"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"C. Mathieu","raw_affiliation_strings":["Department of Endocrinology University Hospital Gasthuisberg Leuven Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology University Hospital Gasthuisberg Leuven Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058016758","display_name":"Chaicharn Deerochanawong","orcid":"https://orcid.org/0000-0001-9666-7050","observed_orcids":["https://orcid.org/0000-0001-9666-7050"]},"institutions":[{"id":"https://openalex.org/I1315836254","display_name":"Ministry of Public Health","ror":"https://ror.org/03rn0z073","country_code":"TH","type":"government","lineage":["https://openalex.org/I1315836254"]},{"id":"https://openalex.org/I4210112079","display_name":"Rajavithi Hospital","ror":"https://ror.org/0238gtq84","country_code":"TH","type":"healthcare","lineage":["https://openalex.org/I4210112079"]},{"id":"https://openalex.org/I89226531","display_name":"Rangsit University","ror":"https://ror.org/01cqcrc47","country_code":"TH","type":"education","lineage":["https://openalex.org/I89226531"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"C. Deerochanawong","raw_affiliation_strings":["Rajavithi hospital, College of Medicine, Rangsit University, Ministry of Public Health, Bangkok, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rajavithi hospital, College of Medicine, Rangsit University, Ministry of Public Health, Bangkok, Thailand","institution_ids":["https://openalex.org/I1315836254","https://openalex.org/I4210112079","https://openalex.org/I89226531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058274800","display_name":"Wolfgang Landgraf","orcid":"https://orcid.org/0000-0001-5321-7164","observed_orcids":["https://orcid.org/0000-0001-5321-7164"]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. Landgraf","raw_affiliation_strings":["Sanofi Frankfurt Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Frankfurt Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021039903","display_name":"C. Candelas","orcid":"https://orcid.org/0000-0003-4216-1681","observed_orcids":["https://orcid.org/0000-0003-4216-1681"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Candelas","raw_affiliation_strings":["Sanofi Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Paris France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041274229","display_name":"Val\u00e9rie Pilorget","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"V. Pilorget","raw_affiliation_strings":["Sanofi Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Paris France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110438636","display_name":"Marie\u2010Paule Dain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M.\u2010P. Dain","raw_affiliation_strings":["Sanofi Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Paris France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087844534","display_name":"Matthew C. Riddle","orcid":"https://orcid.org/0000-0003-1169-3036","observed_orcids":["https://orcid.org/0000-0003-1169-3036"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. C. Riddle","raw_affiliation_strings":["Oregon Health & Science University Portland OR USA","Oregon Health and Science University , Portland, OR , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University Portland OR USA","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"Oregon Health and Science University , Portland, OR , USA","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5108247584"],"corresponding_institution_ids":["https://openalex.org/I84884186"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":1.9619,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.85668555,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"17","issue":"1","first_page":"15","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6025000214576721,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6025000214576721,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.38920000195503235,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neutral-protamine-hagedorn-insulin","display_name":"neutral protamine Hagedorn insulin","score":0.9330000281333923},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.6800000071525574},{"id":"https://openalex.org/keywords/insulin-dose-adjustment","display_name":"insulin dose adjustment","score":0.9150000214576721},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9200000166893005},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9089999794960022},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.6990000009536743},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9700000286102295},{"id":"https://openalex.org/keywords/insulin-naive-patients","display_name":"insulin-naive patients","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.8790512084960938},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7910628318786621},{"id":"https://openalex.org/C2778804033","wikidata":"https://www.wikidata.org/wiki/Q1929845","display_name":"NPH insulin","level":5,"score":0.761069655418396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7596703767776489},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6995823979377747},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6721082925796509},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5939809679985046},{"id":"https://openalex.org/C2780835560","wikidata":"https://www.wikidata.org/wiki/Q5449573","display_name":"Protamine","level":3,"score":0.5266965627670288},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48865512013435364},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.4694221615791321},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44442278146743774},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.40755122900009155},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.3333442509174347},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.06880101561546326},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001208","descriptor_name":"Asia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008877","descriptor_name":"Middle East","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013019","descriptor_name":"South Africa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015190","descriptor_name":"Blood Glucose Self-Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054796","descriptor_name":"Drug Dosage Calculations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1111/dom.12329","doi":"https://doi.org/10.1111/dom.12329","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12329","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12329","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3262808","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4282751","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24957785","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24957785","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:4282751","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4282751/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/469025","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/469025","pdf_url":"https://lirias.kuleuven.be/retrieve/9df40849-b314-48c9-ba70-a875278d4b2f","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes, Obesity & Metabolism, vol. 17 (1), (15-22)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.811.8395","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.811.8395","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/dd/37/dom0017-0015.PMC4282751.pdf","raw_type":"text"},{"id":"doi:10.25405/ncl.34244880.v1","doi":"https://doi.org/10.25405/ncl.34244880.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34244880.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1111/dom.12329","doi":"https://doi.org/10.1111/dom.12329","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12329","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12329","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320315142","display_name":"MannKind Corporation","ror":"https://ror.org/02vbfm330"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2059616065.pdf","grobid_xml":"https://content.openalex.org/works/W2059616065.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1593991603","https://openalex.org/W1978822680","https://openalex.org/W1979786771","https://openalex.org/W2007003907","https://openalex.org/W2015166879","https://openalex.org/W2111876001","https://openalex.org/W2121918915","https://openalex.org/W2126781806","https://openalex.org/W2149194615","https://openalex.org/W2172193326","https://openalex.org/W2410985551","https://openalex.org/W2527670279","https://openalex.org/W2789732774","https://openalex.org/W3003646297"],"related_works":["https://openalex.org/W7221173838","https://openalex.org/W7096546903","https://openalex.org/W1990624369","https://openalex.org/W4239632743","https://openalex.org/W2126781806","https://openalex.org/W2065330837","https://openalex.org/W2053042303","https://openalex.org/W2168959099","https://openalex.org/W2032739316","https://openalex.org/W2003744723"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"examine":[2],"whether":[3],"insulin":[4,78,212,218,252,261],"glargine":[5,68,157,192,206,253],"can":[6],"lead":[7],"to":[8,28,66,81,210,224,262,270],"better":[9],"control":[10,250],"of":[11,73,108,116,122,124,132,144,174],"glycated":[12],"haemoglobin":[13],"(HbA1c)":[14],"than":[15,193,267],"that":[16],"achieved":[17,242],"by":[18,179],"neutral":[19],"protamine":[20],"Hagedorn":[21],"(NPH)":[22],"insulin,":[23],"using":[24],"a":[25,46,105,111,119,128,236],"protocol":[26],"designed":[27],"limit":[29],"nocturnal":[30,86,176,226,244,264],"hypoglycaemia.":[31],"METHODS:":[32],"The":[33,98,172,217],"present":[34],"study,":[35],"the":[36,56,142,202,229,240],"Least":[37],"One":[38],"Oral":[39],"Antidiabetic":[40],"Drug":[41],"Treatment":[42],"(LANCELOT)":[43],"Study,":[44],"was":[45,186,207,221],"36-week,":[47],"randomized,":[48],"open-label,":[49],"parallel-arm":[50],"study":[51,233],"conducted":[52],"in":[53,213,235,243],"Europe,":[54],"Asia,":[55],"Middle":[57],"East":[58],"and":[59,85,127,141,162,170,188],"South":[60],"America.":[61],"Participants":[62],"were":[63,152,199],"randomized":[64],"(1:1)":[65],"begin":[67],"or":[69,183],"NPH,":[70,256],"on":[71],"background":[72],"metformin":[74],"with":[75,146,191,194,251,255],"glimepiride.":[76],"Weekly":[77],"titration":[79],"aimed":[80],"achieve":[82],"median":[83],"prebreakfast":[84],"plasma":[87,180],"glucose":[88,181,273],"levels":[89],"\u22645.5":[90],"mmol/l,":[91,185],"while":[92,246],"limiting":[93],"values":[94,140],"\u22644.4":[95],"mmol/l.":[96],"RESULTS:":[97],"efficacy":[99],"population":[100],"(n":[101],"=":[102],"701)":[103],"had":[104],"mean":[106,112,120,129],"age":[107],"57":[109],"years,":[110],"body":[113],"mass":[114],"index":[115],"29.8":[117],"kg/m\u00b2,":[118],"duration":[121],"diabetes":[123],"9.2":[125],"years":[126],"HbA1c":[130,139,147],"level":[131],"8.2%":[133],"(66":[134],"mmol/mol).":[135],"At":[136],"treatment":[137],"end,":[138],"proportion":[143],"participants":[145],"<7.0":[148],"%":[149,159,167],"(<53":[150],"mmol/mol)":[151,161,169],"not":[153,208,222],"significantly":[154],"different":[155],"for":[156],"[7.1":[158],"(54":[160],"50.3%]":[163],"versus":[164],"NPH":[165,195,211],"[7.2":[166],"(55":[168],"44.3%].":[171],"rate":[173],"symptomatic":[175],"hypoglycaemia,":[177],"confirmed":[178],"\u22643.9":[182],"\u22643.1":[184],"29":[187],"48%":[189],"less":[190],"insulin.":[196],"Other":[197],"outcomes":[198],"similar":[200],"between":[201,228],"groups.":[203],"CONCLUSION:":[204],"Insulin":[205],"superior":[209],"improving":[214],"glycaemic":[215,249],"control.":[216],"dosing":[219],"algorithm":[220],"sufficient":[223],"equalize":[225],"hypoglycaemia":[227,245,265],"two":[230],"insulins.":[231],"This":[232],"confirms,":[234],"globally":[237],"heterogeneous":[238],"population,":[239],"reduction":[241],"attaining":[247],"good":[248],"compared":[254],"even":[257],"when":[258],"titrating":[259],"basal":[260],"prevent":[263],"rather":[266],"treating":[268],"according":[269],"normal":[271],"fasting":[272],"levels.":[274]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}